We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

AbbVie Looks To Ditch FCA Suit Alleging Humira Kickbacks

Law360 (November 1, 2018, 4:24 PM EDT) -- AbbVie Inc. has urged an Illinois federal judge to let it escape a False Claims Act suit over an alleged kickback scheme to boost prescriptions of its blockbuster immunosuppressant drug Humira through the use of a network of nurse “ambassadors.”

The company on Wednesday moved to dismiss the federal suit filed by Florida resident Lazaro Suarez, who worked for AbbVie as a nurse subcontractor. For one thing, AbbVie argued Suarez didn’t sufficiently allege the government ever received any false payment claims — a central part of any FCA claim.  

“His primary falsity theory — that claims for reimbursement of Humira...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Attached Documents

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Illinois Northern

Nature of Suit

375(Other Statutes: False Claims Act)

Judge

Subscribers Only

Date Filed

October 8, 2015

Law Firms

Companies